HDAC11 脱乙基化 BRAF 调节激酶活性和细胞增殖
Augustine C Madueke1, Rafael Andrade1, Mary Kay H Pflum1
1Department of Chemistry, Wayne State University, 5101 Cass Avenue, Detroit, Michigan 48201, United States.
ACS chemical biology
|November 22, 2025
概括
希斯脱乙酶11 (HDAC11) 通过去除乙基来调节蛋白质活性. 这项研究确定了BRAF激酶作为标,表明HDAC11抑制了癌细胞的增殖.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 基因素乙化,由基因素脱乙酶 (HDACs) 调节,在细胞生物学中至关重要.
- 增加HDAC表达与癌症等疾病的预后不佳相关,突出显示HDAC抑制剂的治疗潜力.
- HDAC11,一个研究较少的异型,独特地修改了乙化和脂肪化,表明广泛的细胞功能.
研究的目的:
- 通过基于蛋白质基因的突变诱捕来识别HDAC11的非歇斯顿基质.
- 为了阐明由HDAC11活动调节的特定细胞事件.
- 了解HDAC11在癌症信号通路中的作用.
主要方法:
- 基于蛋白质组学的突变诱捕被用来发现HDAC11基质.
- 进行了后续研究,以验证已识别的基质及其功能后果.
- 研究了BRAF激酶作为HDAC11.11的特定非歇斯顿基质.
主要成果:
- 蛋白质组学分析确定了64个HDAC11.11的假定非希斯基质.
- 发现HDAC11在氨酸残留680 (K680) 中去乙化BRAF激酶.
- 这种HDAC11的脱乙基化抑制了BRAF激酶的活性,并减少了癌细胞的增殖.
结论:
- HDAC11在调节非歇斯顿蛋白功能的过程中起着重要作用,超出了它在基因组修饰中的规范作用.
- 通过HDAC11介导的BRAF激酶脱甲基化会影响癌细胞的增殖和信号通路.
- 这些发现强调了HDAC11的多样性调节功能及其作为癌症治疗点的潜力.
相关概念视频
MAPK Signaling Cascades
7.8K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.8K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
The Ras Gene
7.0K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.0K
The JAK-STAT Signaling Pathway
11.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.8K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K


